Advancing the Vaccine Law Dialogue

Pre-conference: September 13 Washington, D.C.

Richard Wilder

Richard Wilder, JD

Senior Scholar, O’Neill Institute for National and Global Health Law, Georgetown University, Professor of Practice, University of New Hampshire Franklin Pierce School of Law 


Richard Wilder started his professional life in engineering and then studied law – with a particular focus on intellectual property law. Over the past two decades his focus has been on global public health law – including establishing organizations and leading the development of agreements to enable the development, manufacture and distribution of drugs, vaccines and diagnostics intended for global use. A common thread running through Richard’s work in recent years has been how best to ensure access, including how to ensure access to the artifacts of scientific research, including published materials, data, software code and biological materials. 

While serving as a legal advisor to the Global Health Program at the Bill & Melinda Gates Foundation, Richard led the development of the open access policy for publications arising from work funded by the foundation. As General Counsel and Director, Legal and Business Development at the Coalition for Epidemic Preparedness Innovations, he directed the legal and business development affairs of CEPI during its initial start-up phase and through the first two years of the response to the COVID-19 pandemic. Richard also served as a committee member of the Roundtable on Aligning Incentives for Open Science convened by the National Academies of Science, Engineering and Medicine.

Mr. Wilder spoke at the 2022 conference on the following panels:

September 16, 2022 10:30AM-12:00PM — Patent Law, Policy, and Economics of Vaccine Development